Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Prostate Cancer

  Free Subscription


06.02.2017

1 Br J Cancer
1 Cancer
16 J Clin Oncol
2 J Magn Reson Imaging
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Br J Cancer

  1. ROCHETTE A, Boufaied N, Scarlata E, Hamel L, et al
    Asporin is a stromally expressed marker associated with prostate cancer progression.
    Br J Cancer. 2017 Feb 2. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Cancer

  2. PETTERSSON A, Gerke T, Fall K, Pawitan Y, et al
    The ABC model of prostate cancer: A conceptual framework for the design and interpretation of prognostic studies.
    Cancer. 2017 Feb 2. doi: 10.1002/cncr.30582.
    PubMed     Text format     Abstract available


    J Clin Oncol

  3. PORTER KR, Slezak JM, Chien GW, Jacobsen SJ, et al
    Racial and ethnic variation in baseline health-related quality of life scores prior to prostate cancer treatment.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available

  4. DU L, Ahmed IA, Morgans AK
    Education practices in prostate cancer: A comparison of patient and caregiver experiences.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available

  5. TSANG V, Palmer-Hague JL, Wassersug RJ, Nasiopoulos E, et al
    Using eye-tracking to quantify the impact of prostate cancer treatments on male libido: A pilot study.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available

  6. NEWTON RU, Culos-Reed SN, Faithfull S, Lambert S, et al
    An international, population-level initiative to promote healthy lifestyle practices among prostate cancer survivors.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available

  7. MALLAPAREDDI A, Ruterbusch J, Reamer E, Eggly S, et al
    Active surveillance for early stage prostate cancer: What do men and their partners think?
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available

  8. GRANDE D, Crossette L, Bekelman JE, Pollack CE, et al
    Understanding the impact of primary care providers on treatment decisions for men with localized prostate cancer.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available

  9. BIDDLE H, Hunnicutt BA, Trenkner S
    SEASONS: A prospective study assessing the physical, psychosocial, spiritual, and financial needs of patients with breast and prostate cancer.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available

  10. MAY S, Feller JF
    Transrectal MR-guided laser focal therapy of recurrent prostate cancer in a patient post-proton therapy: A case study.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available


  11. Thoughts and experience 10 years post surgery from a cancer researcher and survivor: The burdens of a prostate cancer survivor.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available

  12. DEAL AM, Williams GR, Guerard EJ, Pergolotti M, et al
    Physical activity communication between oncology providers and patients with early stage breast, colon or prostate cancer.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available

  13. LEONG N, Hodgson S, Wambolt E, Hildebrand C, et al
    Development and evaluation of the TrueNTH-Prostate Cancer Canada electronic Library for Improved (urinary and bowel) Function post Treatment (TrueNTH-PCC-eLIFT).
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available

  14. ZAROWSKI C, Dayan M, Pollock P, Elliott S, et al
    Utilization of sexual health and pelvic floor physiotherapy services in Vancouver's Prostate Cancer Supportive Care (PCSC) Program.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available

  15. BORSCH C, Garg B, Dobek JC, Doggett R, et al
    Falls and frailty in prostate cancer survivors on androgen deprivation therapy.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available

  16. POLLOCK P, Wassersug RJ, Zarowski C, Dayan M, et al
    Successful implementation of a disease-specific survivorship program for men with prostate cancer (PC) and their partners.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available

  17. LIN DW, Karsh LI, Shevrin DH, Shore ND, et al
    The TRUMPET registry: Assessing clinical outcomes and quality of life in patients with castration-resistant prostate cancer and their caregivers.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available

  18. FRANKLAND J, Brodie H, Cooke D, Pickering R, et al
    The True NTH Prostate Cancer Survivorship Care programme: Development and evaluation of a model for delivering follow-up care to men with prostate cancer.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available


    J Magn Reson Imaging

  19. WASEDA Y, Yoshida S, Takahara T, Kwee TC, et al
    Utility of computed diffusion-weighted MRI for predicting aggressiveness of prostate cancer.
    J Magn Reson Imaging. 2017 Feb 2. doi: 10.1002/jmri.25593.
    PubMed     Text format     Abstract available

  20. WOLF MB, Edler C, Tichy D, Rothke MC, et al
    Diffusion-weighted MRI treatment monitoring of primary hypofractionated proton and carbon ion prostate cancer irradiation using raster scan technique.
    J Magn Reson Imaging. 2017 Feb 2. doi: 10.1002/jmri.25635.
    PubMed     Text format     Abstract available


    PLoS One

  21. PITCHER B, Khoja L, Hamilton RJ, Abdallah K, et al
    Assessment of a prognostic model, PSA metrics and toxicities in metastatic castrate resistant prostate cancer using data from Project Data Sphere (PDS).
    PLoS One. 2017;12:e0170544.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: